Alok Dalal
Stock Analyst at Jefferies
(2.77)
# 2,792
Out of 4,478 analysts
80
Total ratings
57.9%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Alok Dalal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: EMCURE Emcure Pharmaceuticals Limited | Maintained: Buy | ₹1,970 → ₹2,100 | $1,835.00 | +14.44% | 8 | Jun 24, 2026 | |
| NSE: ALKEM Alkem Laboratories Limited | Maintained: Buy | ₹6,000 → ₹6,500 | $5,598.50 | +16.10% | 5 | May 29, 2026 | |
| NSE: ENTERO Entero Healthcare Solutions Limited | Maintained: Buy | ₹1,350 → ₹1,500 | $1,190.00 | +26.05% | 6 | May 28, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Maintained: Buy | ₹9,120 → ₹9,700 | $8,872.00 | +9.33% | 4 | May 25, 2026 | |
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹3,100 → ₹3,000 | $2,530.30 | +18.56% | 6 | May 20, 2026 | |
| NSE: GLAND Gland Pharma Limited | Maintained: Hold | ₹1,970 → ₹2,080 | $2,463.20 | -15.56% | 4 | May 18, 2026 | |
| NSE: MEDANTA Global Health Limited | Maintained: Buy | ₹1,440 → ₹1,500 | $1,355.00 | +10.70% | 5 | May 18, 2026 | |
| NSE: SAILIFE Sai Life Sciences Limited | Maintained: Buy | ₹1,300 → ₹1,270 | $1,240.00 | +2.42% | 4 | May 18, 2026 | |
| NSE: COHANCE Cohance Lifesciences Limited | Downgraded: Sell | ₹300.00 | $450.00 | -33.33% | 1 | May 13, 2026 | |
| NSE: CIPLA Cipla Limited | Maintained: Sell | ₹1,120 | $1,470.00 | -23.81% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹480.00 → ₹1,100 | $1,528.00 | -28.01% | 3 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,380 → ₹1,500 | $1,132.20 | +32.49% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹2,400 → ₹2,250 | $2,490.00 | -9.64% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | ₹1,210 → ₹1,100 | $1,364.60 | -19.39% | 2 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹1,620 → ₹1,700 | $1,276.00 | n/a | 3 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,350 → ₹1,150 | $1,147.90 | n/a | 3 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹6,280 → ₹6,200 | $6,857.50 | n/a | 2 | May 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹260.00 | $178.00 | n/a | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,850 → ₹3,140 | $3,373.50 | n/a | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹890.00 → ₹650.00 | $430.25 | n/a | 2 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹860.00 → ₹850.00 | $980.05 | n/a | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,260 → ₹2,265 | $1,912.80 | n/a | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | ₹400.00 | $423.80 | n/a | 1 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $68 → $12 | $14.36 | n/a | 4 | Jan 30, 2024 |
Emcure Pharmaceuticals Limited
Jun 24, 2026
Maintained: Buy
Price Target: ₹1,970 → ₹2,100
Current: $1,835.00
Upside: +14.44%
Alkem Laboratories Limited
May 29, 2026
Maintained: Buy
Price Target: ₹6,000 → ₹6,500
Current: $5,598.50
Upside: +16.10%
Entero Healthcare Solutions Limited
May 28, 2026
Maintained: Buy
Price Target: ₹1,350 → ₹1,500
Current: $1,190.00
Upside: +26.05%
Apollo Hospitals Enterprise Limited
May 25, 2026
Maintained: Buy
Price Target: ₹9,120 → ₹9,700
Current: $8,872.00
Upside: +9.33%
Mankind Pharma Limited
May 20, 2026
Maintained: Buy
Price Target: ₹3,100 → ₹3,000
Current: $2,530.30
Upside: +18.56%
Gland Pharma Limited
May 18, 2026
Maintained: Hold
Price Target: ₹1,970 → ₹2,080
Current: $2,463.20
Upside: -15.56%
Global Health Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,440 → ₹1,500
Current: $1,355.00
Upside: +10.70%
Sai Life Sciences Limited
May 18, 2026
Maintained: Buy
Price Target: ₹1,300 → ₹1,270
Current: $1,240.00
Upside: +2.42%
Cohance Lifesciences Limited
May 13, 2026
Downgraded: Sell
Price Target: ₹300.00
Current: $450.00
Upside: -33.33%
Cipla Limited
May 8, 2026
Maintained: Sell
Price Target: ₹1,120
Current: $1,470.00
Upside: -23.81%
May 4, 2026
Maintained: Hold
Price Target: ₹480.00 → ₹1,100
Current: $1,528.00
Upside: -28.01%
Aug 14, 2025
Maintained: Buy
Price Target: ₹1,380 → ₹1,500
Current: $1,132.20
Upside: +32.49%
Aug 7, 2025
Upgraded: Buy
Price Target: ₹2,400 → ₹2,250
Current: $2,490.00
Upside: -9.64%
Jul 24, 2025
Maintained: Sell
Price Target: ₹1,210 → ₹1,100
Current: $1,364.60
Upside: -19.39%
May 31, 2025
Maintained: Hold
Price Target: ₹1,620 → ₹1,700
Current: $1,276.00
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ₹1,350 → ₹1,150
Current: $1,147.90
Upside: n/a
May 18, 2025
Maintained: Hold
Price Target: ₹6,280 → ₹6,200
Current: $6,857.50
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: ₹260.00
Current: $178.00
Upside: n/a
Apr 30, 2025
Maintained: Buy
Price Target: ₹2,850 → ₹3,140
Current: $3,373.50
Upside: n/a
Apr 25, 2025
Maintained: Hold
Price Target: ₹890.00 → ₹650.00
Current: $430.25
Upside: n/a
Feb 10, 2025
Maintained: Buy
Price Target: ₹860.00 → ₹850.00
Current: $980.05
Upside: n/a
Jan 31, 2025
Maintained: Buy
Price Target: ₹2,260 → ₹2,265
Current: $1,912.80
Upside: n/a
Jan 6, 2025
Upgraded: Hold
Price Target: ₹400.00
Current: $423.80
Upside: n/a
Jan 30, 2024
Downgraded: Sell
Price Target: $68 → $12
Current: $14.36
Upside: n/a